Metraipolis › archive › dc_35f5f645fd5b

KMT2D loss drives adeno-to-squamous transition and sensitizes TKI-resistant lung cancer to AURKA inhibition — Europe PMC PMID:41507359

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41507359
DOI
10.1038/s41418-[numero omesso]-7
License (as archived)
solo-consultazione
Archived
2026-11-06T23:42:05.295Z
SHA-256 of the archived text
1bd3f5295b80779eb12ae099d35db1920945615b7a5490d981f48b769ada51c7
Stable URL of this page
https://metraipolis.com/documento/dc_35f5f645fd5b

How to cite

KMT2D loss drives adeno-to-squamous transition and sensitizes TKI-resistant lung cancer to AURKA inhibition — Europe PMC PMID:41507359 — Europe PMC (en), https://europepmc.org/article/MED/41507359 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_35f5f645fd5b (Metraipolis archive dc_35f5f645fd5b, sha256 1bd3f5295b80779eb12ae099d35db1920945615b7a5490d981f48b769ada51c7)
BibTeX
@misc{dc35f5f645fd5b,
  title = {KMT2D loss drives adeno-to-squamous transition and sensitizes TKI-resistant lung cancer to AURKA inhibition — Europe PMC PMID:41507359},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41507359},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_35f5f645fd5b; sha256 1bd3f5295b80779eb12ae099d35db1920945615b7a5490d981f48b769ada51c7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41507359. Agents can read the archived copy with the MCP tool read_document.